Expression of both Cdk5 and its activator Cdk5r1 (p35) were increased at the mRNA level in WT CKD but remained near baseline in CG1-KO kidneys in all 3 CKD models tested (Figure 5C and Supplemental Figure 5, A and B). This evidence concerns the gene CDK5R1 and chronic kidney disease.